We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
THE LEE COMPANY

Download Mobile App




New Rapid Molecular Test Detects Bacteria and Viruses With 93.33% Accuracy

By LabMedica International staff writers
Posted on 28 Sep 2023
Print article
Image: Researchers have developed a new rapid electronic diagnostic test for infectious diseases (Photo courtesy of 123RF)
Image: Researchers have developed a new rapid electronic diagnostic test for infectious diseases (Photo courtesy of 123RF)

In March of 2020, the World Health Organization declared that SARS-CoV-2, commonly known as the coronavirus, had reached pandemic status. Since that time, close to six million lives have been lost, and approximately two million new infections are being recorded globally each day. To manage outbreaks like COVID-19, which have a huge impact on both public health and the worldwide economy, there is a need for diagnostic tools that are quick, reliable, sensitive, and easily accessible. Scientists have now developed a new molecular test that can detect various bacteria and viruses, including SARS-CoV-2, setting the stage for better preparedness for future pandemics.

A research team at the University of Surrey (Surrey, UK) has developed a new molecular test, called ‘Electro-chemical LAMP’ (eLAMP). This test is not only affordable and rapid but also highly sensitive and can be administered either at home, in a general practitioner's office, or in a hospital lab. eLAMP shares the sensitivity of laboratory-based PCR tests, and when paired with a smartphone, can easily be conducted at home. The test converts the output of another PCR-like test known as LAMP into a simple electric current.

The device used for this electrochemical test is already quite small, and the research team plans to make it even more compact equivalent to the size of a memory stick that can be controlled through a smartphone app. This would enable patients to carry out the test at home and promptly send the results to healthcare services, aiding in monitoring the spread of infections. Additionally, the patients would receive immediate medical guidance. The test, when used on human blood, saliva, and nasal and throat swabs, demonstrated a detection accuracy of 93.33%. It also works efficiently at room temperature, generating results in just 45 minutes.

"A key lesson we took from the COVID-19 pandemic is how crucial rapid, effective and cheap diagnostic tools that can be used at home are to monitoring and containing infectious diseases,” said Professor Johnjoe McFadden, corresponding author of the study and Professor of Molecular Genetics at the University of Surrey. “Our test meets these criteria and can detect lower amounts of the SARS-CoV-2 virus compared to other home-based tests. We are looking for commercial partners to further develop the test and take it to market."

"SARS-CoV-2 is likely to be around for a long time and, unfortunately, new difficult viruses are likely to emerge,” added Dr. Khushboo Borah Slater, co-author of the study from the University of Surrey. “It's crucial to keep working on better ways to test for the coronavirus, and our goal is to further develop our test so that it can be easily used everywhere to help control the disease and prevent future outbreaks."

Related Links:
University of Surrey 

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
Gold Supplier
Pipette Controller
Sapphire MaxiPette
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Sample Collection
Saliva Collection Media

Print article

Channels

Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Hematology

view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more

Immunology

view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more

Microbiology

view channel
Image: Current testing methods for antibiotic susceptibility rely on growing bacterial colonies in the presence of antibiotics (Photo courtesy of 123RF)

Rapid Antimicrobial Susceptibility Test Returns Results within 30 Minutes

In 2019, antimicrobial resistance (AMR) was responsible for the deaths of approximately 1.3 million individuals. The conventional approach for testing antimicrobial susceptibility involves cultivating... Read more

Pathology

view channel
Image: AI methods used in satellite imaging can help researchers analyze tumor images (Photo courtesy of Karolinska Institutet)

AI Approach Combines Satellite Imaging and Ecology Techniques for Analysis of Tumor Tissue

Advancements in tumor imaging technology have significantly enhanced our ability to observe the minute details of tumors, but this also brings the challenge of interpreting vast amounts of data generated... Read more

Industry

view channel
Image: The acquisition significantly expands Medix Biochemica’s portfolio of IVD raw materials (Photo courtesy of ViroStat)

Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering

Medix Biochemica (Espoo, Finland), a supplier of critical raw materials to the in vitro diagnostics (IVD) industry, has acquired ViroStat LLC (Portland, ME, USA), a provider of infectious disease antibodies... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.